Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;45(2):171-177.
doi: 10.1002/pd.6712. Epub 2024 Nov 25.

Parental Somatic Mosaicism Detected During Prenatal Diagnosis

Affiliations

Parental Somatic Mosaicism Detected During Prenatal Diagnosis

Natalie J Chandler et al. Prenat Diagn. 2025 Feb.

Abstract

Objective: Accurate recurrence risks are essential for genomic counselling and parental reproductive choices. Historically, Sanger sequencing was used to test parental samples, which has a limited sensitivity of ∼ 10% for detecting somatic mosaicism. Next generation sequencing (NGS) methods, utilised for non-invasive prenatal diagnosis (NIPD) and trio prenatal exome sequencing in our laboratory, have greater sensitivity. Here we review the cases of parental somatic mosaicism we have detected and discuss its impact on management.

Method: Laboratory databases from 1 January 2015 to 30 September 2022 were reviewed to identify all cases where parental somatic mosaicism was detected during NIPD and prenatal exome testing.

Results: During the development of NIPD testing, we identified 10/131 (7.6%) families with parental somatic mosaicism. In six cases where NGS detected levels between 0.37% and 8.82%, prior testing with Sanger sequencing had not detected mosaicism. In our exome sequencing cohort, we detected parental mosaicism in 4/101 (3.96%) cases. Clinical features of the condition were identified in 2/14 parents.

Conclusion: The sensitivity of the testing technique needs to be considered when counselling parents on recurrence risk. Parents need to be aware that modern approaches to prenatal diagnosis may allow identification of mosaicism, which may have implications for their own health and change recurrence risks for future pregnancies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
A comparison of Sanger sequencing and PCR capture next generation sequencing results of parental and affected proband genomic DNA samples for selected cases ((A)—Case 6; (B)—Case 4; (C)—Case 7; (D)—Case 14); see Supporting Information S1: Figures 1–3 for all cases. For the Sanger sequencing traces, all variants occur at the middle peak in each image. The middle panel in each figure shows traces from the sample tested, the other sequence trace is from a normal control sample (either top or bottom depending on if forward or reverse) and the other panel is the electropherogram traces comparing the peaks detected in the sample trace in comparison to the normal control. Red arrows indicate signs of mosaicism and black arrows indicate background noise causing mosaicism to be missed. PCR capture Next Generation Sequencing results are given as the number of reads for the wild type and variant sequences. The percentage VAF has also been calculated using the values in red indicating somatic mosaicism.

References

    1. Rahbari R., Wuster A., Lindsay S. J., et al., “Timing, Rates and Spectra of Human Germline Mutation,” Nature Genetics 48, no. 2 (2016): 126–133, 10.1038/ng.3469. - DOI - PMC - PubMed
    1. Jonsson H., Sulem P., Arnadottir G. A., et al., “Multiple Transmissions of De Novo Mutations in Families,” Nature Genetics 50, no. 12 (2018): 1674–1680, 10.1038/s41588-018-0259-9. - DOI - PubMed
    1. Wright C. F., Prigmore E., Rajan D., et al., “Clinically‐Relevant Postzygotic Mosaicism in Parents and Children With Developmental Disorders in Trio Exome Sequencing Data,” Nature Communications 10, no. 1 (2019): 2985, 10.1038/s41467-019-11059-2. - DOI - PMC - PubMed
    1. Xu X., Yang X., Wu Q., et al., “Amplicon Resequencing Identified Parental Mosaicism for Approximately 10% of ‘De Novo’ SCN1A Mutations in Children With Dravet Syndrome,” Human Mutation 36, no. 9 (2015): 861–872, 10.1002/humu.22819. - DOI - PMC - PubMed
    1. Chen Z., Moran K., Richards‐Yutz J., et al., “Enhanced Sensitivity for Detection of Low‐Level Germline Mosaic RB1 Mutations in Sporadic Retinoblastoma Cases Using Deep Semiconductor Sequencing,” Human Mutation 35, no. 3 (2014): 384–391, 10.1002/humu.22488. - DOI - PMC - PubMed

Publication types